AzTrials
AzTrials

Eye InjuriesNCT02638025

Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury

An observational study of Eye Injuries, run by Huizhou Municipal Central Hospital.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study use anterior segment spectral-domain optical coherence tomography (SD-OCT) to exam patients with closed globe injury, and compared with slit lamp examination. The results showed that OCT can identify features of closed globe injury that were otherwise not visible on slit lamp biomicroscopy. Read more about this study

Who is it for?
Any age
Conditions the study is for
Eye Injuries
What is being tested?
OCT
Type of treatment
Medical device
How many people
16 participants
Where
No sites listed yet
Study dates
Jan 2010to Jul 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: patients with closed globe injury were recruited, and all eyes of recruited patients had hyphema occupying at least 1/3rd of anterior chamber volume

Who may be able to join

  • patients with closed globe injury were recruited; had hyphema at least 1/3 of anterior chamber volume

Who cannot join

  • can not cooperate with examination

About this study

This study use anterior segment spectral-domain optical coherence tomography (SD-OCT) to exam patients with closed globe injury, and compared with slit lamp examination. The results showed that OCT can identify features of closed globe injury that were otherwise not visible on slit lamp biomicroscopy.

Read the detailed description

The anterior segment architecture changes of closed globe injury patients include corneal damage, hyphema, angle recession and lens dislocation, which can be showed with OCT. OCT was superior to slit lamp biomicroscopy examination in detecting anterior segment architecture changes, especially in the presence of media opacities.

Conditions
Eye Injuries
Being tested
OCT
Medical subject headings
Eye Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • OCTDevice

    Anterior Segment Spectral-domain Optical Coherence Tomography

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. anterior segment spectral-domain optical coherence tomography (SD-OCT) findings in patients with closed globe injury

    Measured: within 24 hours after patients were admitted

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2015 (estimated)
  2. Study startJan 2010
  3. Primary completionJul 2011
  4. Study completionJul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02638025
Sponsor's protocol ID
HMCH20151216
Status last verified
Dec 2015
First submitted
16 Dec 2015
Last updated
22 Dec 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Eye Injuries, run by Huizhou Municipal Central Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

anterior segment spectral-domain optical coherence tomography (SD-OCT) findings in patients with closed globe injury (time frame: within 24 hours after patients were admitted). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in